Cited by 36Gestational Diabetes Research and ManagementMaternal and Neonatal HealthcareDiabetes Management and Research

Perinatal Outcomes in Early and Late Gestational Diabetes Mellitus After Treatment From 24–28 Weeks’ Gestation: A TOBOGM Secondary Analysis

Simmons, David, Immanuel, Jincy, Hague, William M., Teede, Helena, Nolan, Christopher J., Peek, Michael J., Flack, Jeff R., McLean, Mark +38 more·2024·Diabetes Care

Abstract

Objective In most gestational diabetes mellitus (GDM) studies, cohorts have included women combined into study populations without regard to whether hyperglycemia was present earlier in pregnancy. In this study we sought to compare perinatal outcomes between groups: women with early GDM (EGDM group: diagnosis before 20 weeks' gestation but no treatment until 24-28 weeks' gestation if GDM still present), with late GDM (LGDM group: present only at 24-28 weeks' gestation), and with normoglycemia at 24-28 weeks' gestation (control participants). Research design and methods This is a secondary analysis of a randomized controlled treatment trial where we studied, among women with risk factors, early ( Results Women with EGDM (n = 254) and LGDM (n = 467) had shorter pregnancy duration than control participants (n = 2,339). BMI was lowest with LGDM. The composite was increased with EGDM (odds ratio [OR] 1.59, 95% CI 1.18-2.12) but not LGDM (OR 1.19, 95% CI 0.94-1.50). Induction of labor was higher in both GDM groups. In comparisons with control participants there were higher birth centile, higher preterm birth rate, and higher rate of neonatal jaundice for the EGDM group (but not the LGDM group). The greatest need for insulin and/or metformin was with EGDM. Conclusions Adverse perinatal outcomes were increased with EGDM despite treatment from 24-28 weeks' gestation, suggesting the need to initiate treatment early, and more aggressively, to reduce the effects of exposure to the more s…

Integrity signals

Registry

Crossref · 10.2337/dc23-1667

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A secondary analysis of the TOBOGM study showed that adverse perinatal outcomes were increased with GDM diagnosed during the first half of pregnancy, despite treatment from 24 to 28 weeks' gestation, compared with GDM diagnosed during the second half of pregnancy.

    “GDM diagnosed during the first half of pregnancy, despite treatment from 24 to 28 weeks' gestation, compared with GDM diagnosed during the second half of pregnancy 16 .”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Simmons, D., Immanuel, J., Hague, W. M., Teede, H., Nolan, C. J., Peek, M. J., Flack, J. R., McLean, M., Wong, V., Hibbert, E. J., Kautzky-Willer, A., Harreiter, J., Backman, H., Gianatti, E., Sweeting, A., Mohan, V., Cheung, N. W., TOBOGM Research Group, Simmons, D., Cheung, N. W., Immanuel, J., Hague, W. M., Teede, H., Nolan, C. J., Peek, M. J., Flack, J. R., McLean, M., Wong, V., Hibbert, E., Gianatti, E., Sweeting, A., Coat, S., Dalal, R., Soldatos, G., Padmanabhan, S., Rajagopal, R., Rudland, V., Harreiter, J., Kautzky-Willer, A., Kiss, H., Backman, H., Schwarcz, E., Ross, G., Mohan, V., Mohan Anjana, R., & Ram, U.
Affiliations
9Nepean Clinical School, University of Sydney, and Nepean Hospital, Sydney, New South Wales, Australia
Venue
Diabetes Care
Published
2024-02-29
Volume
47
Issue
12
Pages
2093-2101
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W4392297962
Cited by
36
References
5
Citations by year
2026: 20 · 2025: 9 · 2024: 7
FWCI
19.83
Type
journal article
Language
en
Open access
closed
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
  • ANU Open Research (Australian National University) (submittedVersion)
Funders
  • South Western Sydney Local Health District Academic Unit
  • Medical Scientific Fund of the Mayor of Vienna (project numbers 15205 and 23026)
  • National Health and Medical Research Council (1104231, 2009326)
  • Region Örebro Research Committee (15205, 23026, OLL-942177, OLL-970566)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Health Sciences › Health Professions › General Health Professions › Maternal and Neonatal Healthcare
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
gestational diabetes mellitus, perinatal outcomes, hyperglycemia in pregnancy, preterm birth, birth weight, neonatal jaundice, labor induction, insulin therapy, metformin, gestation length, birth trauma, neonatal respiratory distress, stillbirth, shoulder dystocia
MeSH terms
Adult, Birth Weight, Female, Gestational Age, Humans, Infant, Newborn, Pregnancy, Pregnancy Outcome, Diabetes, Gestational

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review